Gosset 5-hydroxytryptamine receptor 5A Overview
5-hydroxytryptamine receptor 5A (5-HT5A) is a G protein-coupled receptor encoded by the HTR5A gene in humans. It couples primarily to G_i/o proteins, thus inhibiting adenylate cyclase activity and decreasing intracellular cAMP. The receptor is mainly expressed in the brain, where it regulates neurotransmitter release, synaptic plasticity, and may function as a presynaptic serotonin autoreceptor. The 5-HT5A receptor is implicated in cognitive processes, mood regulation, and is a potential therapeutic target for conditions such as depression, schizophrenia, psychosis, and neuropathic pain. Its physiological and pathological functions are less well-understood compared to other serotonin receptor subtypes, in part due to a historical lack of selective ligands and structural data, but recent advances provide a basis for drug development and further characterization.
Mechanism of Action
Agonists: Decrease cAMP via G_i/o coupling, modulate neurotransmitter release, potentially act as inhibitory autoreceptors. Antagonists: Block Gi/o signaling, may counteract serotonergic inhibition in the brain and affect neuromodulatory processes
Biological Functions
Disease Associations
Safety Considerations
- Limited selectivity of current ligands may affect other serotonin and GPCR subtypes
- Incomplete understanding of physiological and pathological roles
- Potential for CNS side effects due to broad distribution and function
- No established on-target toxicity as clinical drugs are not yet in widespread use
Interacting Drugs
Associated Biomarkers
| Biomarker |
|---|
| mRNA expression levels in brain regions |
| Density of 5-HT5A immunolabeling in specific CNS regions |